购物车
- 全部删除
- 您的购物车当前为空
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg | ¥ 12,400 | 期货 | |
100 mg | ¥ 17,400 | 期货 |
产品描述 | Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. |
靶点活性 | GT3a:0.90±0.2 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT1a:0.01±0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT1b:0.01±<0.01 nM (Ki) |
别名 | MK-5172 potassium salt, MK 5172 potassium, Grazoprevir potassium |
分子量 | 805 |
分子式 | C38H49KN6O9S |
CAS No. | 1206524-86-8 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容